ISOO × SIOP: A Global Alliance to Transform Retinoblastoma Care

Why This Partnership Matters

The International Society of Ocular Oncology (ISOO) and the International Society of Paediatric Oncology (SIOP) have formalized a strategic alliance that unites the world’s leading ocular and paediatric oncology experts. Together, we aim to accelerate progress in the diagnosis, treatment, and long-term care of children with retinoblastoma.

What You Can Expect

  • Joint Education & Events
    Look for co-branded webinars, conference tracks, and virtual roundtables that blend ISOO’s ophthalmic expertise with SIOP’s paediatric oncology network.

  • Collaborative Research & Guidelines
    Cross-disciplinary working groups will develop evidence-based guidelines, launch multicentre studies, and share best practices—cutting edge knowledge delivered straight to the clinic.

  • Stronger Advocacy on the Global Stage
    As a non-state actor in official relations with the World Health Organization, SIOP will invite ISOO leaders to co-author statements, position papers, and proposals that shape international policy on childhood eye cancers.

  • Member Access & Savings
    ISOO and SIOP members will enjoy streamlined access to each other’s meetings, with reduced-rate registration for designated sessions and networking events.

Leadership & Representation

ISOO’s President and President-Elect will serve as official delegates within SIOP’s retinoblastoma initiatives, ensuring ophthalmology’s voice is front and centre. Likewise, SIOP will designate a representative to liaise with ISOO, fostering seamless coordination across projects.

Coming Up First

  • Kick-off Webinar (July 2025): “Bridging Ocular & Paediatric Oncology in Retinoblastoma Care”—details and registration link arriving soon.

  • Joint Session at ISOO Virtual 2025: An interactive panel featuring ISOO and SIOP experts on emerging therapies and global care pathways.

Get Involved

  1. Subscribe to our newsletter for alliance updates.

  2. Share your research ideas—look for an upcoming call for proposals.

  3. Attend the kick-off events and bring your questions.

Stay tuned as we roll out more opportunities to learn, connect, and innovate—because together, we can change the trajectory of retinoblastoma treatment worldwide.